Survivin is an attractive potential target for cancer therapies because it is rarely expressed in normal cells but remarkably unregulated in several types of cancers.29 The results of HNSCC tissue array that included 57 cases have also confirmed the higher expression of survivin in the nuclei of cancer cells than in those of normal mucosa. The gene discussed is BIRC5; the disease is head and neck squamous cell carcinoma.